Universitair Ziekenhuis Leuven - Campus Gasthuisberg

Leuven, Flemish Brabant 3000

1 studies enrolling now · 7 studies all time

What they study most

Advanced or Metastatic NSCLS With Exon 20 Insertion Mutation, Duchenne Muscular Dystrophy, Liver Stiffness, Myelofibrosis, NASH - Nonalcoholic Steatohepatitis, Patients With Non-Small Cell Lung Cancer, Primary Biliary Cholangitis, Solid Tumor

Studies at this site

• Trial of Therapeutic Cancer Vaccine OSE2101 in Patients With Non-Small Cell Lung Cancer and Secondary Resistance to Immune Checkpoint Inhibitor — Recruiting now
• REZILIENT3 (REsearching ZIpaLertinib In Egfr Non-small Cell Lung Cancer Tumors) — Running, not enrolling
• A Phase 3 Study Evaluating Efficacy and Safety of Lanifibranor Followed by an Active Treatment Extension in Adult Patients With (NASH) and Fibrosis Stages F2 and F3 ( NATiV3 ) — Running, not enrolling
• Study of Selinexor in Combination With Ruxolitinib in Myelofibrosis — Running, not enrolling
• Study of PYX-106 in Solid Tumors — Running, not enrolling
• A Trial of Setanaxib in Patients With Primary Biliary Cholangitis (PBC) and Liver Stiffness — Completed
• Phase 3 Trial of Pamrevlumab or Placebo in Combination With Systemic Corticosteroids in Participants With Ambulatory DMD — Stopped early